Related Articles for PubMed (Select 18312646)

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.

Nora T, Bouchonnet F, Labrosse B, Charpentier C, Mammano F, Clavel F, Hance AJ.

Retrovirology. 2008 Feb 29;5:23.

PMID: 18312646 [PubMed - indexed for MEDLINE]

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31.

PMID: 18614865 [PubMed - indexed for MEDLINE]

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

Peters PJ, Duenas-Decamp MJ, Sullivan WM, Brown R, Ankghuambom C, Luzuriaga K, Robinson J, Burton DR, Bell J, Simmonds P, Ball J, Clapham PR.

Retrovirology. 2008 Jan 18;5:5.

PMID: 18205925 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, Galvao-Castro B, von Briesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn BH.

J Virol. 1996 Mar;70(3):1651-67.

PMID: 8627686 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.

Ray N, Harrison JE, Blackburn LA, Martin JN, Deeks SG, Doms RW.

J Virol. 2007 Apr;81(7):3240-50. Epub 2007 Jan 24.

PMID: 17251281 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients.

Labrosse B, Morand-Joubert L, Goubard A, Rochas S, Labernardière JL, Pacanowski J, Meynard JL, Hance AJ, Clavel F, Mammano F.

J Virol. 2006 Sep;80(17):8807-19.

PMID: 16912327 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization.

Reeves JD, Lee FH, Miamidian JL, Jabara CB, Juntilla MM, Doms RW.

J Virol. 2005 Apr;79(8):4991-9.

PMID: 15795284 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.

Skrabal K, Saragosti S, Labernardière JL, Barin F, Clavel F, Mammano F.

J Virol. 2005 Sep;79(18):11848-57.

PMID: 16140761 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.

Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U.

Retrovirology. 2008 Mar 7;5:25.

PMID: 18328091 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

10:

Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding.

Rainwater SM, Wu X, Nduati R, Nedellec R, Mosier D, John-Stewart G, Mbori-Ngacha D, Overbaugh J.

Curr HIV Res. 2007 Mar;5(2):189-97.

PMID: 17346133 [PubMed - indexed for MEDLINE]

11:

Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.

Braibant M, Agut H, Rouzioux C, Costagliola D, Autran B, Barin F.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):274-84.

PMID: 18197126 [PubMed - indexed for MEDLINE]

12:

A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.

Zhang PF, Bouma P, Park EJ, Margolick JB, Robinson JE, Zolla-Pazner S, Flora MN, Quinnan GV Jr.

J Virol. 2002 Jan;76(2):644-55.

PMID: 11752155 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

13:

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC.

Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905.

PMID: 12019106 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

14:

Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.

Argañaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J.

J Biol Chem. 2003 Sep 5;278(36):33912-9. Epub 2003 Jun 19.

PMID: 12816953 [PubMed - indexed for MEDLINE]

15:

An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.

van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C.

AIDS. 1997 Jan;11(1):81-7.

PMID: 9110079 [PubMed - indexed for MEDLINE]

16:

Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.

Painter SL, Biek R, Holley DC, Poss M.

J Virol. 2003 Aug;77(15):8448-61.

PMID: 12857914 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

17:

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.

Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J.

AIDS. 2007 Mar 30;21(6):693-702.

PMID: 17413690 [PubMed - indexed for MEDLINE]

18:

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.

Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC.

J Virol. 2006 Dec;80(23):11776-90. Epub 2006 Sep 13.

PMID: 16971434 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

19:

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.

Charpentier C, Nora T, Tenaillon O, Clavel F, Hance AJ.

J Virol. 2006 Mar;80(5):2472-82.

PMID: 16474154 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

20:

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.

De Wolf F, Hogervorst E, Goudsmit J, Fenyö EM, Rübsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SD, et al.

AIDS Res Hum Retroviruses. 1994 Nov;10(11):1387-400.

PMID: 7888192 [PubMed - indexed for MEDLINE]

Recent Activity